Constructive Bio’s 2025 achievements in non-canonical amino acid (ncAA) incorporation include expanded platform capabilities, new partnerships, and recognition from Nature…
Constructive Bio was selected by Nature Biotechnology as a 2025 Editor’s Pick, recognising the company’s synthetic genomics platform and use…
Constructive Bio is contributing its large-scale genome assembly platform to an ARIA-funded collaboration with Camena Bioscience and the Max-Planck Institute…
Constructive Bio was Highly Commended in the Biotech Company of the Year category at the Cambridge Independent Science and Technology…
The Sunday Times named Constructive Bio a ‘Biotech One to Watch’ in its 2025 100 Tech Awards, recognising the Cambridge-based…
Constructive Bio was named Best Performing R&D Platform Development Company of the Year at the One Nucleus Awards, recognising the…
Constructive Bio secured $58 million in Series A financing, bringing total funding to $75 million, to scale its BioForge fermentation…
Constructive Bio expanded to new headquarters in the Cambridge Biomedical Cluster, taking all lab space at Gen Two in Whittlesford…
Engineering the future of biology with revolutionary genome synthesis and expanded genetic code technology.
QUICK LINKS
JOIN OUR NEWSLETTER
© 2026 Constructive Bio. All rights reserved.